CR20140528A - Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de Bace1 - Google Patents

Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de Bace1

Info

Publication number
CR20140528A
CR20140528A CR20140528A CR20140528A CR20140528A CR 20140528 A CR20140528 A CR 20140528A CR 20140528 A CR20140528 A CR 20140528A CR 20140528 A CR20140528 A CR 20140528A CR 20140528 A CR20140528 A CR 20140528A
Authority
CR
Costa Rica
Prior art keywords
hexahydro
difluoro
cyclopentaoxacinyls
benzooxacinyls
bace1 inhibitors
Prior art date
Application number
CR20140528A
Other languages
English (en)
Inventor
Hans Hilpert
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20140528A publication Critical patent/CR20140528A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Abstract

La presente invención proporciona diflouroro-ciclopentaoxacinilos y difluoroenzooxacinilos de fórmula I
CR20140528A 2012-06-26 2014-11-18 Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de Bace1 CR20140528A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12173690 2012-06-26
PCT/EP2013/063086 WO2014001228A1 (en) 2012-06-26 2013-06-24 Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors

Publications (1)

Publication Number Publication Date
CR20140528A true CR20140528A (es) 2015-01-12

Family

ID=48672630

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140528A CR20140528A (es) 2012-06-26 2014-11-18 Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de Bace1

Country Status (22)

Country Link
US (1) US9181232B2 (es)
EP (1) EP2864324B1 (es)
JP (1) JP6251257B2 (es)
KR (1) KR20150023450A (es)
CN (1) CN104470915B (es)
AU (1) AU2013283524B2 (es)
BR (1) BR112014029742A2 (es)
CA (1) CA2872181A1 (es)
CL (1) CL2014003325A1 (es)
CO (1) CO7151509A2 (es)
CR (1) CR20140528A (es)
EA (1) EA025273B1 (es)
HK (1) HK1206344A1 (es)
IL (1) IL236138A (es)
MA (1) MA37763B1 (es)
MX (1) MX2014014937A (es)
NZ (1) NZ702253A (es)
PE (1) PE20142450A1 (es)
PH (1) PH12014502623B1 (es)
SG (1) SG11201407576YA (es)
UA (1) UA113309C2 (es)
WO (1) WO2014001228A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130018370A (ko) 2008-06-13 2013-02-20 시오노기세야쿠 가부시키가이샤 β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
WO2011071135A1 (ja) † 2009-12-11 2011-06-16 塩野義製薬株式会社 オキサジン誘導体
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
WO2014134341A1 (en) 2013-03-01 2014-09-04 Amgen Inc. Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
EP2964644B1 (en) 2013-03-08 2018-12-26 Amgen, Inc. Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
TW201623295A (zh) 2014-04-11 2016-07-01 塩野義製藥股份有限公司 具有ｂａｃｅ１抑制活性之二氫噻及二氫衍生物
MX2017001794A (es) 2014-08-08 2017-06-29 Amgen Inc Compuestos de tiazin-2-amina fusionados con ciclopropilo como inhibidores de beta-secretasa y metodos de uso.
RU2712272C2 (ru) 2015-03-20 2020-01-28 Ф. Хоффманн-Ля Рош Аг Ингибиторы бета-секретазы
US11629154B2 (en) 2018-04-27 2023-04-18 Shionogi & Co., Ltd. Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010047372A1 (ja) 2008-10-22 2012-03-22 塩野義製薬株式会社 Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
GB0912778D0 (en) * 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
WO2011071135A1 (ja) * 2009-12-11 2011-06-16 塩野義製薬株式会社 オキサジン誘導体

Also Published As

Publication number Publication date
KR20150023450A (ko) 2015-03-05
CA2872181A1 (en) 2014-01-03
US20150133440A1 (en) 2015-05-14
JP2015521640A (ja) 2015-07-30
HK1206344A1 (en) 2016-01-08
EA025273B1 (ru) 2016-12-30
NZ702253A (en) 2016-06-24
PH12014502623A1 (en) 2015-01-21
AU2013283524A1 (en) 2014-11-13
CL2014003325A1 (es) 2015-04-24
PE20142450A1 (es) 2015-01-28
MA37763B1 (fr) 2017-05-31
US9181232B2 (en) 2015-11-10
EA201590066A1 (ru) 2015-04-30
SG11201407576YA (en) 2015-03-30
UA113309C2 (xx) 2017-01-10
PH12014502623B1 (en) 2015-01-21
MX2014014937A (es) 2015-03-09
WO2014001228A1 (en) 2014-01-03
BR112014029742A2 (pt) 2017-06-27
IL236138A0 (en) 2015-02-01
JP6251257B2 (ja) 2017-12-20
CN104470915A (zh) 2015-03-25
IL236138A (en) 2016-10-31
EP2864324A1 (en) 2015-04-29
CO7151509A2 (es) 2014-12-29
EP2864324B1 (en) 2018-03-28
AU2013283524B2 (en) 2017-03-30
CN104470915B (zh) 2019-07-26
MA37763A1 (fr) 2016-08-31

Similar Documents

Publication Publication Date Title
CY1119105T1 (el) Παραγωγα διπυραζολιου ως αναστολεις jak
CR20140528A (es) Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de Bace1
CO7111289A2 (es) Compuestos inhibidores de metaloenzimas
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
CO7091177A2 (es) Inhibidores de la beta-secretasa
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
UY34836A (es) Nuevo organismos
UY34472A (es) Derivados modificados de 4-fenil-piridina
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
CO6801773A2 (es) Espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
UY34523A (es) Derivados de betulina
CR20140535A (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
BR112015012907A2 (pt) composição de cuidado pessoal
BR112014026926A2 (pt) uso terapêutico de produtos de semente de chardonnay
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
UY34287A (es) Protector universal de roscas de caños
BR112014000022A2 (pt) 1-3-tiazepinas ciclopropil-fundidas como inibidores de bace 1 e/ou bace 2
CR20140495A (es) 5-amino[1,4]thiazines como inhibidores de bace1
BR112014026634A2 (pt) direcionador
BR112014027219A2 (pt) método
IL236963A0 (en) beta-secretase inhibitors
UY4181Q (es) Taza
BR112015001072A2 (pt) misturas refrigerantes